Ohly announced that it immediately agreed to divest its Hutchinson (Minn.) Torula Yeast facility and associated Torula whole cell business to Lallemand, a leading global producer of yeast and bacteria based products.
Officials said the divestiture follows a strategic review by Ohly to find a partner to better utilize and sustainably secure the future of the Hutchinson site.
“We are proud of the vital role that the Hutchinson site has played in enabling Ohly Americas to expand in the North American yeast market,” said Ralf Fink, CEO Ohly. “We believe this transfer of ownership will yield important benefits for our partners, customers and employees by ensuring the continued delivery of whole cell yeast products to its existing customers whilst providing job security for the Hutchinson site team, whose valuable contributions we are deeply grateful for.”
Ohly will continue to operate globally and within the US out of its Boyceville, Wis., facility, now being able to focus on Torula yeast extract based specialties and PRODRY® culinary powders.
Therefore, as part of the divestiture agreement Lallemand and Ohly have entered into a long-term supply partnership to supply Ohly with cream raw material from Hutchinson for use in all downstream products at Boyceville.
“Lallemand is already a well-established global supplier of inactive yeast products for savory and health food applications,” said Lars Asferg, president and general manager of Lallemand Bio-ingredients. “The acquisition of the Hutchinson business will provide our new and existing customers with a wider choice of products and taste profiles and further develop our technology leadership. We are delighted to have formed a supply partnership with Ohly demonstrating our long term commitment to the specialty inactive yeast sector.”
Ohly is one of the world’s leading suppliers of yeast-based specialty products for the global food, fermentation, feed and health markets. Ohly is part of the ABF Ingredients group (ABFI) who develops, produces and markets Specialty ingredients for the Food, Beverage and Nutrition, Feed, Pharmaceutical sectors, as well as for a variety of other industrial applications.
Visit https://www.ohly.com/en for more details.
Lallemand is a privately owned Canadian group specializing in the research, development, production, marketing and distribution of yeast and bacteria for use in the food ingredients, human nutrition, animal nutrition, baking, wine, beer, biofuels and pharmaceutical industries. Lallemand has approximately 4,000 employees located in more than 40 countries, on all continents and operates 23 yeast and 8 bacteria plants. The Lallemand group President & CEO is Antoine Chagnon. www.lallemand.com.